Cargando…
Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals
The global efforts in the past few months have led to the discovery of around 200 drug repurposing candidates for COVID-19. Although most of them only exhibited moderate anti-SARS-CoV-2 activity, gaining more insights into their mechanisms of action could facilitate a better understanding of infecti...
Autores principales: | Xing, Jing, Paithankar, Shreya, Liu, Ke, Uhl, Katie, Li, Xiaopeng, Ko, Meehyun, Kim, Seungtaek, Haskins, Jeremy, Chen, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941614/ https://www.ncbi.nlm.nih.gov/pubmed/33688643 http://dx.doi.org/10.1101/2021.03.04.433931 |
Ejemplares similares
-
Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals
por: Xing, Jing, et al.
Publicado: (2021) -
Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern
por: Kim, Tai Young, et al.
Publicado: (2022) -
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020) -
Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
por: Xing, Jing, et al.
Publicado: (2022) -
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)
por: Lee, Jihye, et al.
Publicado: (2021)